Hepatitis_NP C_NP Virus_NP Genotyping_NP :_: Interrogation_NN of_IN the_DT 5_CD '_POS Untranslated_NP Region_NP Cannot_NP Accurately_NP Distinguish_NP Genotypes_NP 1a_NP and_CC 1b_NP Although_IN the_DT 5_CD '_POS untranslated_JJ region_NN (_( 5_CD '_POS UTR_NN )_) is_VBZ the_DT most_RBS conserved_VBN region_NN of_IN the_DT hepatitis_NP C_NP virus_NN (_( HCV_NP )_) genome_NN ,_, it_PP has_VBZ been_VBN suggested_VBN that_DT interrogation_NN of_IN this_DT region_NN is_VBZ sufficient_JJ for_IN determination_NN of_IN the_DT HCV_NP genotype_NN ._SENT We_PP compared_VBD two_CD methods_NNS of_IN determination_NN of_IN the_DT HCV_NP genotype_NN :_: (_( i_NP )_) direct_JJ sequencing_VBG of_IN the_DT DNA_NN of_IN the_DT NS-5b_NP region_NN and_CC (_( ii_NNS )_) reverse_JJ line_NN probe_NN assay_NN (_( LiPA_NP ;_: INNO-LiPA_NP HCV_NP II_NP ;_: Innogenetics_NP N.V._NP )_) of_IN the_DT 5_CD '_POS UTR_NP ._SENT There_EX was_VBD 100_CD %_NN concordance_NN between_IN the_DT two_CD methods_NNS for_IN genotype_NN but_CC only_RB 80_CD %_NN concordance_NN for_IN subtype_NN ._SENT A_DT significant_JJ percentage_NN of_IN genotype_NN 1a_NN isolates_NNS were_VBD misclassified_VBN by_IN LiPA_NP as_IN genotype_NN 1b_NN ._SENT Sequence_NN analysis_NN revealed_VBD that_IN the_DT only_JJ consistent_JJ difference_NN in_IN the_DT 5_CD '_POS UTR_NP for_IN these_DT genotype_NN 1a_NN isolates_NNS misclassified_VBN as_IN genotype_NN 1b_NN was_VBD a_DT single_JJ nucleotide_NN (_( A/G_NP )_) at_IN position_NN -99_CD of_IN the_DT HCV_NP genome_NN ._SENT All_DT isolates_NNS with_IN discordant_JJ results_NNS analyzed_VBD had_VBD a_DT G_NN at_IN this_DT position_NN ,_, consistent_JJ with_IN LiPA_NP determination_NN of_IN these_DT samples_NNS as_IN subtype_NN 1b_NN ._SENT However_RB ,_, sequence_NN analysis_NN of_IN 222_CD nucleotides_NNS in_IN the_DT NS-5b_NP region_NN clearly_RB identified_VBN all_RB of_IN these_DT isolates_NNS as_IN subtype_NN 1a_NP ._SENT Population_NN distribution_NN data_NNS from_IN the_DT University_NP of_IN Pittsburgh_NP Medical_NP Center_NP of_IN over_IN 200_CD samples_NNS analyzed_VBN by_IN sequencing_VBG of_IN the_DT NS-5b_NP region_NN and_CC over_IN 1,000_CD samples_NNS analyzed_VBN by_IN LiPA_NP also_RB indicated_VBD that_IN INNO-LiPA_NP HCV_NP II_NP cannot_MD accurately_RB differentiate_VB HCV_NP genotype_NN 1a_NP isolates_VBZ from_IN HCV_NP genotype_NN 1b_NP isolates_VBZ ._SENT We_PP provide_VBP evidence_NN that_IN the_DT A/G_NN at_IN position_NN -99_CD represents_VBZ a_DT sequence_NN polymorphism_NN in_IN the_DT HCV_NP genome_NN that_WDT cannot_MD differentiate_VB subtype_NN 1a_NN from_IN subtype_NN 1b_JJ isolates_NNS ._SENT In_IN conclusion_NN ,_, the_DT 5_CD '_POS UTR_NN is_VBZ not_RB heterogeneous_JJ enough_RB for_IN use_NN in_IN determination_NN of_IN the_DT HCV_NP subtype_NN and_CC cannot_MD be_VB used_VBN for_IN differentiation_NN of_IN HCV_NP genotypes_NNS 1a_NP and_CC 1b_NP ._SENT Hepatitis_NP C_NP virus_NN (_( HCV_NP )_) is_VBZ an_DT enveloped_VBN positive_JJ single-stranded_JJ RNA_NP virus_NN which_WDT is_VBZ the_DT major_JJ cause_NN of_IN chronic_JJ hepatitis_NN worldwide_RB ._SENT Chronic_JJ hepatitis_NN resulting_VBG from_IN HCV_NP infection_NN may_MD lead_VB to_TO severe_JJ sequelae_NNS ,_, including_VBG hepatic_JJ cirrhosis_NN and_CC hepatocellular_JJ carcinoma_NN ._SENT HCV_NP demonstrates_VBZ a_DT high_JJ degree_NN of_IN sequence_NN variation_NN throughout_IN its_PP$ genome_NN and_CC exists_VBZ in_IN vivo_RB as_IN a_DT group_NN of_IN heterogeneous_JJ but_CC closely_RB related_VBN quasispecies_NNS ._SENT However_RB ,_, the_DT levels_NNS of_IN heterogeneity_NN differ_VBP considerably_RB among_IN the_DT various_JJ regions_NNS of_IN the_DT virus_NN ,_, ranging_VBG from_IN as_RB little_JJ as_IN 10_CD %_NN in_IN the_DT 5_CD '_POS untranslated_JJ region_NN (_( 5_CD '_POS UTR_NN )_) to_TO 50_CD %_NN or_CC more_JJR within_IN the_DT E1_JJ region_NN ._SENT Based_VBN on_IN the_DT analysis_NN of_IN variable_JJ coding_VBG regions_NNS in_IN the_DT viral_JJ genome_NN ,_, distinct_JJ genotypes_NNS as_RB well_RB as_IN subtypes_NNS have_VBP been_VBN defined_VBN ._SENT The_DT distribution_NN of_IN HCV_NP genotypes_NNS differs_VBZ geographically_RB ,_, with_IN subtype_NN 1a_NN being_VBG most_RBS common_JJ in_IN the_DT United_NP States_NP ,_, subtype_NN 1b_NN being_VBG most_RBS common_JJ in_IN Europe_NP and_CC Japan_NP ,_, and_CC other_JJ genotypes_NNS being_VBG prevalent_JJ in_IN other_JJ parts_NNS of_IN the_DT world_NN (_( for_IN a_DT review_NN ,_, see_VBP reference_NN )_) ._SENT Several_JJ studies_NNS have_VBP shown_VBN that_IN HCV_NP genotype_NN influences_VBZ the_DT response_NN to_TO therapy_NN with_IN alpha_NN interferon_NN alone_RB or_CC in_IN combination_NN with_IN ribavirin_NN ._SENT In_IN general_NN ,_, HCV_NP type_NN 2_CD and_CC 3_CD isolates_NNS have_VBP higher_JJR rates_NNS of_IN response_NN to_TO therapy_NN than_IN type_NN 1_CD isolates_NNS ._SENT In_IN addition_NN ,_, some_DT studies_NNS suggest_VBP that_DT genotype_NN alone_RB may_MD predict_VB disease_NN severity_NN ;_: e.g._FW ,_, patients_NNS infected_VBN with_IN HCV_NP genotype_NN 1a_NP or_CC 1b_NP may_MD exhibit_VB more_RBR severe_JJ liver_NN disease_NN (_( ,_, ,_, ,_, -_: ,_, -_: )_) ._SENT These_DT findings_NNS indicate_VBP an_DT important_JJ role_NN of_IN genotype_NN identification_NN for_IN prediction_NN of_IN the_DT outcome_NN of_IN HCV_NP infection_NN and_CC the_DT selection_NN of_IN patients_NNS for_IN treatment_NN protocols_NNS ._SENT Identification_NN of_IN the_DT HCV_NP genotype_NN by_IN interrogation_NN of_IN several_JJ different_JJ regions_NNS of_IN the_DT HCV_NP genome_NN has_VBZ been_VBN reported_VBN ._SENT A_DT wealth_NN of_IN phylogenetic_JJ information_NN has_VBZ been_VBN derived_VBN from_IN sequence_NN analysis_NN of_IN the_DT NS-5_NP gene_NN of_IN HCV_NP ._SENT We_PP have_VBP determined_VBN HCV_NP genotypes_NNS using_VBG direct_JJ sequencing_VBG of_IN the_DT DNA_NN of_IN the_DT NS-5b_NP region_NN for_IN several_JJ years_NNS and_CC have_VBP devised_VBN an_DT algorithm_NN of_IN sequence_NN analysis_NN for_IN genotype_NN determination_NN on_IN the_DT basis_NN of_IN the_DT sequence_NN of_IN this_DT region_NN ._SENT Although_IN sequence_NN analysis_NN is_VBZ considered_VBN the_DT "_`` gold_JJ standard_NN "_'' for_IN HCV_NP genotype_NN determination_NN ,_, it_PP is_VBZ expensive_JJ ,_, time-consuming_JJ ,_, and_CC inconvenient_JJ for_IN routine_JJ use_NN ._SENT A_DT commercial_JJ assay_NN is_VBZ available_JJ which_WDT allows_VBZ rapid_JJ analysis_NN for_IN the_DT HCV_NP genotype_NN via_IN a_DT reverse_JJ hybridization_NN line_NN probe_NN assay_NN (_( LiPA_NP )_) of_IN the_DT 5_CD '_POS UTR_NP of_IN HCV_NP (_( INNO-LiPA_NP HCV_NP II_NP ;_: Innogenetics_NP N.V._NP ,_, Zwijnaarde_NP ,_, Belgium_NP )_) ._SENT The_DT 5_CD '_POS UTR_NP is_VBZ the_DT most_RBS highly_RB conserved_VBN region_NN among_IN HCV_NP strains_NNS ._SENT This_DT makes_VBZ this_DT region_NN theoretically_RB superior_JJ for_IN sensitivity_NN but_CC limits_VBZ its_PP$ usefulness_NN for_IN determining_VBG differences_NNS between_IN various_JJ subtypes_NNS ._SENT However_RB ,_, phylogenetic_JJ analysis_NN of_IN sequence_NN information_NN obtained_VBN from_IN the_DT 5_CD '_POS UTR_NP has_VBZ correlated_VBN fairly_RB well_RB with_IN phylogenetic_JJ analysis_NN of_IN sequence_NN information_NN obtained_VBN from_IN other_JJ regions_NNS of_IN the_DT viral_JJ genome_NN ,_, including_VBG the_DT core_NN ,_, NS-3_NP ,_, NS-4_NP ,_, and_CC NS-5_NP regions_NNS ._SENT In_IN this_DT study_NN ,_, we_PP compared_VBD the_DT HCV_NP genotypes_NNS determined_VBN by_IN direct_JJ sequencing_VBG of_IN the_DT DNA_NN of_IN the_DT NS-5b_NP region_NN and_CC LiPA_NP analysis_NN of_IN the_DT 5_CD '_POS UTR_NP for_IN 63_CD samples_NNS and_CC report_VB our_PP$ experience_NN with_IN genotyping_NN of_IN over_RB 1,000_CD samples_NNS analyzed_VBN by_IN one_CD or_CC both_DT methods_NNS over_IN 5_CD years_NNS ._SENT Samples_NNS ._SENT |_SYM Fresh_NP plasma_NN or_CC liver_NN biopsy_NN specimens_NNS sent_VBD to_TO the_DT Laboratory_NN of_IN Molecular_NP Diagnostics_NP at_IN the_DT University_NP of_IN Pittsburgh_NP Medical_NP Center_NP for_IN routine_JJ HCV_NP genotype_NN analysis_NN over_IN the_DT past_JJ 5_CD years_NNS were_VBD analyzed_VBN ._SENT A_DT total_NN of_IN 247_CD samples_NNS were_VBD analyzed_VBN by_IN NS-5b_NP sequence_NN analysis_NN from_IN 1996_CD to_TO 1998_CD ;_: a_DT total_NN of_IN 1,035_CD samples_NNS were_VBD analyzed_VBN by_IN LiPA_NP from_IN 1998_CD to_TO 2001_CD ._SENT A_DT total_NN of_IN 63_CD samples_NNS that_WDT were_VBD representative_JJ of_IN the_DT genotypes_NNS identified_VBN in_IN our_PP$ laboratory_NN were_VBD initially_RB selected_VBN for_IN comparison_NN of_IN genotyping_NN by_IN the_DT two_CD different_JJ methods_NNS ._SENT Sequencing_VBG analysis_NN of_IN both_CC the_DT NS-5b_NP region_NN and_CC the_DT 5_CD '_POS UTR_NN was_VBD performed_VBN for_IN a_DT number_NN of_IN samples_NNS for_IN which_WDT LiPA_NP gave_VBD discrepant_JJ or_CC indeterminate_JJ results_NNS ._SENT Analysis_NN of_IN these_DT samples_NNS was_VBD done_VBN in_IN compliance_NN with_IN federal_JJ and_CC institutional_JJ review_NN board_NN policies_NNS ._SENT cDNA_NN preparation_NN ._SENT |_SYM RNA_NP was_VBD extracted_VBN from_IN 230_CD mul_NN of_IN plasma_NN or_CC 3-mm3_JJ liver_NN biopsy_NN samples_NNS with_IN the_DT TRIzol_NP reagent_NN (_( GIBCO-BRL_NP [_SYM now_RB Invitrogen_NP ]_SYM ,_, Carlsbad_NP ,_, Calif._NP )_) ,_, precipitated_VBD with_IN isopropanol_NN ,_, and_CC resuspended_VBD in_IN 20_CD mul_NN of_IN diethyl_NN pyrocarbonate-treated_JJ water_NN ._SENT cDNA_NN was_VBD prepared_VBN from_IN 3_CD mul_NN of_IN plasma_NN RNA_NP or_CC 500_CD ng_NNS of_IN liver_NN RNA_NP ._SENT The_DT RNA_NP was_VBD heated_VBN for_IN 5_CD min_NN at_IN 70C_NP and_CC quick_JJ chilled_VBN on_IN ice_NN ;_: and_CC then_RB 7_CD mul_NN of_IN a_DT pre-master_NN mixture_NN containing_VBG 22_CD pmol_NN of_IN random_JJ hexamers_NNS (_( GIBCO-BRL_NP )_) ,_, 50_CD mM_NP Tris-HCl_NP (_( pH_NN 8.3_CD )_) ,_, 7.5_CD mM_NP KCl_NP ,_, 3_CD mM_NP MgCl2_NP ,_, 10_CD mM_NP dithiothreitol_NN ,_, 0.2_CD mM_NNS (_( each_DT )_) deoxynucleoside_NN triphosphate_NN (_( Pharmacia_NP ,_, Peapack_NP ,_, N.J._NP )_) ,_, and_CC 20_CD U_NN of_IN RNase_NP inhibitor_NN (_( Promega_NP ,_, Madison_NP ,_, Wis._NP )_) was_VBD added_VBN ._SENT A_DT total_NN of_IN 100_CD U_NN of_IN Moloney_NP murine_JJ leukemia_NN virus_NN reverse_NN transcriptase_NN (_( GIBCO-BRL_NP )_) was_VBD added_VBN ,_, and_CC the_DT mixture_NN was_VBD incubated_VBN at_IN 37C_JJ for_IN 60_CD min_NN ._SENT LiPA_NP ._SENT |_SYM RNA_NP purification_NN and_CC cDNA_NN preparation_NN were_VBD performed_VBN as_IN described_VBN above_IN ._SENT Analysis_NN of_IN the_DT 5_CD '_POS UTR_NN was_VBD then_RB carried_VBN out_RP with_IN the_DT INNO-LiPA_NP HCV_NP II_NP kit_NN (_( Innogenetics_NP N.V._NP )_) according_VBG to_TO the_DT instructions_NNS of_IN the_DT manufacturer_NN ._SENT Briefly_RB ,_, biotinylated_JJ primers_NNS are_VBP used_VBN to_TO amplify_VB the_DT 5_CD '_POS UTR_NP region_NN of_IN HCV_NP by_IN PCR_NP ._SENT The_DT biotin-labeled_JJ PCR_NP products_NNS are_VBP then_RB reverse_RB hybridized_VBN to_TO type-specific_JJ probes_NNS attached_VBN to_TO nitrocellulose_NN strips_NNS ._SENT Development_NN results_NNS in_IN a_DT purple_JJ or_CC brown_JJ precipitate_NN as_IN a_DT positive_JJ line_NN on_IN the_DT strip_NN ._SENT The_DT HCV_NP type_NN and_CC subtype_NN were_VBD deduced_VBN on_IN the_DT basis_NN of_IN the_DT patterns_NNS of_IN hybridizing_VBG bands_NNS by_IN using_VBG the_DT INNO-LiPA_NP HCV_NP II_NP interpretation_NN chart_NN ._SENT PCR_NP of_IN the_DT NS-5b_NP and_CC 5_CD '_'' UTR_NN regions_NNS ._SENT |_SYM PCR_NP amplification_NN was_VBD performed_VBN with_IN the_DT primers_NNS described_VBN below_IN in_IN a_DT model_JJ 9600_CD thermocycler_NN (_( Perkin-Elmer_NP )_) with_IN 10_CD mul_NN of_IN cDNA_NN in_IN a_DT total_JJ reaction_NN volume_NN of_IN 50_CD mul_NN containing_VBG each_DT primer_NN at_IN 10_CD pmol_NN ,_, 10_CD mM_NP Tris-HCl_NP (_( pH_NN 8.3_CD )_) ,_, 50_CD mM_NP KCl_NP ,_, 1.5_CD mM_NP MgCl2_NP ,_, each_DT deoxynucleoside_NN triphosphate_NN at_IN a_DT concentration_NN of_IN 200_CD muM_NN ,_, and_CC 1.0_CD U_NN of_IN Taq_NP DNA_NP polymerase_NN (_( Perkin-Elmer_NP )_) ._SENT After_IN an_DT initial_JJ denaturation_NN step_NN at_IN 95C_NN for_IN 1_CD min_NN ,_, 40_CD cycles_NNS of_IN PCR_NP at_IN 95C_NN for_IN 20_CD s_NNS ,_, 56C_NN for_IN 30_CD s_NNS ,_, and_CC 72C_NP for_IN 1_CD min_NN were_VBD carried_VBN out_RP ,_, with_IN a_DT final_JJ extension_NN of_IN 72C_NP for_IN 10_CD min_NN ._SENT Nested_VBN PCR_NP of_IN the_DT NS-5b_NP region_NN was_VBD performed_VBN with_IN 1_CD mul_NN of_IN the_DT first-round_JJ amplification_NN product_NN if_IN the_DT amplification_NN product_NN was_VBD not_RB sufficient_JJ for_IN sequence_NN analysis_NN ._SENT Twenty-five_JJ cycles_NNS of_IN the_DT nested_VBN PCR_NP were_VBD carried_VBN out_RP by_IN using_VBG the_DT same_JJ conditions_NNS described_VBN above_IN ,_, except_IN that_WDT an_DT annealing_VBG temperature_NN of_IN 60C_NP was_VBD used_VBN ._SENT First-round_JJ amplification_NN of_IN the_DT NS-5b_NP region_NN was_VBD done_VBN with_IN a_DT sense_NN primer_NN specific_JJ to_TO bases_NNS 7904_CD to_TO 7922_CD (_( 5'-TGG_NP GGT_NP TCT_NP CGT_NP ATG_NP ATA_NP CCC-3_NP '_'' )_) and_CC an_DT antisense_NN primer_NN specific_JJ to_TO bases_NNS 8295_CD to_TO 8275_CD (_( 5'-CCT_NN GGT_NP CAT_NP AGC_NP CTC_NP CGT_NP GAA-3_NP '_'' )_) ._SENT Nested_VBN PCR_NP primers_NNS for_IN detection_NN of_IN the_DT NS-5b_NP region_NN were_VBD a_DT sense_NN primer_NN specific_JJ to_TO bases_NNS 7916_CD to_TO 7935_CD (_( 5'-GAT_NP ACC_NP CGC_NP TGC_NP TTT_NP GAC_NP TC-3_NP '_'' )_) and_CC an_DT antisense_NN primer_NN specific_JJ to_TO bases_NNS 8284_CD to_TO 8266_CD (_( 5'-CCT_NN CCG_NP TGA_NP AGG_NP CTC_NP TCA_NP G-3_NP '_'' )_) ._SENT PCR_NP primers_NNS for_IN detection_NN of_IN the_DT 5_CD '_POS UTR_NN were_VBD a_DT sense_NN primer_NN specific_JJ to_TO bases_NNS -333_CD to_TO -317_CD (_( 5'-CCG_NP ATT_NP GGG_NP GGC_NP GAC_NP AC_NP 3_CD '_'' )_) and_CC an_DT antisense_NN primer_NN specific_JJ to_TO bases_NNS 05_CD to_TO -14_CD (_( 5'-CTC_NP ATG_NP GTG_NP CAC_NP GGT_NP CTA_NP C-3_NP '_'' )_) ._SENT The_DT nucleotide_NN numbering_VBG for_IN the_DT primers_NNS is_VBZ according_VBG to_TO the_DT prototype_NN HCV_NP type_NN 1_CD sequence_NN ._SENT All_DT primers_NNS were_VBD manufactured_VBN by_IN GIBCO-BRL_NP ._SENT Direct_NP sequencing_NP of_IN PCR_NP products_NNS ._SENT |_SYM PCR_NP products_NNS were_VBD purified_VBN with_IN MicroCon-100_NP filters_NNS and_CC were_VBD sequenced_VBN with_IN standard_NN or_CC Big_NP Dye_NP terminator_NN kits_NNS (_( Perkin-Elmer_NP )_) on_IN an_DT automated_JJ ABI373_NP or_CC ABI377XL_NP instrument_NN ._SENT The_DT sequencing_VBG primer_NN for_IN the_DT NS-5b_NP region_NN was_VBD a_DT sense_NN primer_NN specific_JJ to_TO bases_NNS 7916_CD to_TO 7935_CD (_( 5'-GAT_NP ACC_NP CGC_NP TGC_NP TTT_NP GAC_NP TC-3_NP '_'' )_) ._SENT Sequencing_VBG of_IN the_DT 5_CD '_POS UTR_NN was_VBD performed_VBN in_IN both_DT directions_NNS for_IN 6_CD samples_NNS that_WDT gave_VBD discrepant_JJ results_NNS by_IN the_DT two_CD methods_NNS and_CC for_IN 10_CD samples_NNS that_WDT gave_VBD indeterminate_JJ results_NNS by_IN LiPA_NP by_IN using_VBG a_DT sense_NN primer_NN specific_JJ to_TO bases_NNS -333_CD to_TO -317_CD (_( 5'-CCG_NP ATT_NP GGG_NP GGC_NP GAC_NP AC-3_NP '_'' )_) and_CC an_DT antisense_NN primer_NN specific_JJ to_TO bases_NNS 05_CD to_TO -14_CD (_( 5'-CTC_NP ATG_NP GTG_NP CAC_NP GGT_NP CTA_NP C-3_NP '_'' )_) ._SENT Sequence_NN analysis_NN of_IN the_DT NS-5b_NP region_NN ._SENT |_SYM We_PP have_VBP devised_VBN an_DT algorithm_NN for_IN determination_NN of_IN HCV_NP genotype_NN based_VBN on_IN sequence_NN analysis_NN of_IN the_DT NS-5b_NP region_NN (_( Z._NP Chen_NP and_CC J._NP A._NP Kant_NP ,_, unpublished_JJ data_NNS )_) ._SENT Briefly_RB ,_, by_IN using_VBG consensus_NN nucleotide_NN sequences_NNS from_IN a_DT 222-bp_JJ region_NN within_IN the_DT HCV_NP NS-5b_NP region_NN ,_, three_CD or_CC four_CD key_JJ nucleotides_NNS that_WDT are_VBP specifically_RB associated_VBN with_IN major_JJ types_NNS of_IN HCV_NP were_VBD first_RB selected_VBN ._SENT These_DT nucleotides_NNS are_VBP shared_VBN by_IN each_DT subtype_NN within_IN major_JJ types_NNS ._SENT Another_DT 5_CD to_TO 11_CD key_JJ nucleotides_NNS specifically_RB associated_VBN with_IN subtypes_NNS within_IN major_JJ HCV_NP types_NNS were_VBD then_RB chosen_VBN ._SENT Determination_NN of_IN the_DT type_NN and_CC subtype_NN of_IN HCV_NP in_IN each_DT patient_JJ sample_NN was_VBD made_VBN on_IN the_DT basis_NN of_IN the_DT presence_NN of_IN these_DT key_JJ nucleotides_NNS that_WDT had_VBD been_VBN identified_VBN ._SENT In_IN addition_NN ,_, the_DT alignments_NNS of_IN the_DT sequenced_JJ 222-bp_JJ region_NN with_IN the_DT NS-5b_NP region_NN was_VBD determined_VBN for_IN each_DT patient_JJ sample_NN by_IN using_VBG consensus_NN HCV_NP subtype_NN sequences_NNS ,_, and_CC the_DT total_JJ number_NN of_IN mismatches_NNS per_IN 222_CD bp_NN was_VBD determined_VBN for_IN each_DT subtype_NN within_IN the_DT assigned_JJ type_NN ._SENT Typically_RB ,_, we_PP find_VBP fewer_JJR than_IN 15_CD mismatches_NNS per_IN 222_CD bp_NN for_IN samples_NNS of_IN the_DT same_JJ HCV_NP subtype_NN (_( >93_JJ %_NN similarity_NN )_) and_CC greater_JJR than_IN 30_CD mismatches_NNS per_IN 222_CD bp_NN for_IN samples_NNS of_IN different_JJ HCV_NP subtypes_NNS (_( <86_JJ %_NN similarity_NN )_) ._SENT This_DT is_VBZ consistent_JJ with_IN proposed_VBN similarities_NNS for_IN classification_NN of_IN HCV_NP genotype_NN on_IN the_DT basis_NN of_IN the_DT sequence_NN of_IN the_DT NS-5_NP gene_NN ._SENT For_IN all_DT samples_NNS analyzed_VBD ,_, determination_NN of_IN genotype_NN based_VBN on_IN this_DT algorithm_NN correlated_VBN with_IN the_DT results_NNS obtained_VBN by_IN sequence_NN analysis_NN with_IN the_DT BLAST_NP program_NN ._SENT Restriction_NN enzyme_NN digestion_NN ._SENT |_SYM Restriction_NP enzyme_NN analysis_NN of_IN the_DT 5_CD '_POS UTR_NN was_VBD performed_VBN for_IN a_DT subset_NN of_IN samples_NNS that_WDT were_VBD genotype_NN 1_CD by_IN LiPA_NP but_CC whose_WP$ subtypes_NNS could_MD not_RB be_VB determined_VBN ._SENT A_DT total_NN of_IN 20_CD mul_NN of_IN purified_VBN reverse_JJ transcription-PCR_NN (_( RT-PCR_NP )_) products_NNS from_IN the_DT 5_CD '_POS UTR_NN were_VBD digested_VBN with_IN Alw26I_NP at_IN 37C_JJ for_IN 3_CD h_NN and_CC analyzed_VBD on_IN a_DT 2_CD %_NN agarose_NN gel_NN stained_VBN with_IN ethidium_NN bromide_NN ._SENT Comparison_NN of_IN HCV_NP genotype_NN by_IN NS-5b_NP sequence_NN analysis_NN and_CC LiPA_NP ._SENT |_SYM A_DT total_NN of_IN 63_CD samples_NNS were_VBD analyzed_VBN by_IN both_DT NS-5b_NP sequence_NN analysis_NN and_CC LiPA_NP in_IN a_DT comparative_JJ analysis_NN ._SENT The_DT genotypes_NNS of_IN the_DT samples_NNS selected_VBN for_IN the_DT comparative_JJ analysis_NN were_VBD representative_JJ of_IN the_DT genotypes_NNS identified_VBN in_IN our_PP$ laboratory_NN by_IN NS-5b_NP sequencing_NP in_IN order_NN to_TO evaluate_VB the_DT performance_NN of_IN the_DT INNO-LiPA_NP HCV_NP II_NP kit_NN ._SENT There_EX was_VBD 100_CD %_NN concordance_NN between_IN the_DT two_CD methods_NNS for_IN type_NN and_CC 80_CD %_NN concordance_NN for_IN subtype_NN ._SENT LiPA_NP failed_VBD to_TO assign_VB a_DT subtype_NN to_TO four_CD (_( 6_CD %_NN )_) samples_NNS ._SENT Of_IN the_DT samples_NNS that_WDT were_VBD assigned_VBN a_DT subtype_NN by_IN both_DT methods_NNS ,_, there_EX were_VBD discrepant_JJ subtyping_VBG results_NNS for_IN 9_CD of_IN 63_CD (_( 14_CD %_NN )_) samples_NNS ._SENT One_CD sample_NN was_VBD called_VBN subtype_NN 2b_JJ by_IN NS-5b_NP sequence_NN analysis_NN and_CC subtype_NN 2a/2c_JJ by_IN LiPA_NP ._SENT LiPA_NP cannot_MD discriminate_VB between_IN subtypes_NNS 2a_JJ and_CC 2c_JJ ._SENT The_DT remainder_NN of_IN the_DT samples_NNS with_IN discrepant_JJ results_NNS (_( 13_CD %_NN of_IN the_DT total_NN )_) were_VBD called_VBN subtype_NN 1b_JJ by_IN LiPA_NP and_CC subtype_NN 1a_NN by_IN NS-5b_NP sequence_NN analysis_NN ._SENT Of_IN the_DT 37_CD samples_NNS identified_VBN as_IN subtype_NN 1a_NP by_IN NS-5b_NP sequence_NN analysis_NN ,_, 22_CD %_NN were_VBD classified_VBN as_IN subtype_NN 1b_NN by_IN LiPA_NP ._SENT NS-5b_NP sequence_NN analysis_NN of_IN samples_NNS with_IN discrepant_JJ results_NNS ._SENT |_SYM Figure_NN shows_VBZ the_DT results_NNS of_IN NS-5b_NP sequence_NN analysis_NN for_IN the_DT eight_CD samples_NNS with_IN discrepant_JJ results_NNS that_WDT were_VBD subtyped_VBN as_IN HCV_NP subtype_NN 1b_NN by_IN LiPA_NP and_CC subtype_NN 1a_NN by_IN NS-5b_NP sequence_NN analysis_NN ._SENT All_DT of_IN the_DT samples_NNS with_IN discrepant_JJ results_NNS were_VBD sequenced_JJ at_IN least_JJS twice_RB in_IN order_NN to_TO confirm_VB their_PP$ classification_NN as_IN type_NN 1a_NP ._SENT The_DT eight_CD samples_NNS each_DT demonstrated_VBD six_CD to_TO seven_CD of_IN the_DT seven_CD nucleotides_NNS identified_VBN as_IN key_JJ nucleotides_NNS for_IN genotype_NN 1a_NP ._SENT In_IN contrast_NN ,_, none_NN of_IN these_DT samples_NNS had_VBD any_DT of_IN the_DT 11_CD nucleotides_NNS identified_VBN as_IN key_NN for_IN genotype_NN 1b_NN ._SENT In_IN addition_NN ,_, the_DT alignments_NNS of_IN the_DT sequences_NNS with_IN consensus_NN sequences_NNS for_IN subtypes_NNS 1a_NP and_CC 1b_NP ,_, as_RB described_VBN by_IN Simmonds_NP et_FW al._FW ,_, were_VBD compared_VBN ._SENT The_DT total_JJ number_NN of_IN mismatches_NNS was_VBD significantly_RB higher_JJR with_IN subtype_NN 1b_JJ consensus_NN sequences_NNS than_IN with_IN subtype_NN 1a_NP consensus_NN sequences_NNS for_IN all_DT eight_CD isolates_NNS analyzed_VBD ._SENT This_DT corresponds_VBZ to_TO 95.5_CD to_TO 98.6_CD %_NN nucleotide_NN identity_NN with_IN the_DT subtype_NN 1a_NP consensus_NN sequence_NN and_CC 77_CD to_TO 85_CD %_NN nucleotide_NN identity_NN with_IN the_DT subtype_NN 1b_JJ consensus_NN sequence_NN ,_, thus_RB confirming_VBG the_DT identification_NN of_IN all_DT eight_CD of_IN these_DT samples_NNS as_IN HCV_NP genotype_NN 1a_NP ._SENT 5_LS '_POS UTR_NP sequence_NN analysis_NN of_IN samples_NNS with_IN discrepant_JJ results_NNS ._SENT |_SYM In_IN order_NN to_TO investigate_VB the_DT discrepancy_NN further_RBR ,_, we_PP sequenced_VBD the_DT DNA_NN of_IN the_DT 5_CD '_POS UTR_NP region_NN (_( the_DT region_NN interrogated_VBN by_IN LiPA_NP )_) for_IN six_CD of_IN the_DT eight_CD samples_NNS with_IN discrepant_JJ results_NNS for_IN subtype_NN 1a_NP and_CC 1b_NP and_CC for_IN control_NN subtype_NN 1a_NN and_CC subtype_NN 1b_JJ samples_NNS ._SENT The_DT only_JJ consistent_JJ difference_NN in_IN the_DT 5_CD '_POS UTR_NP for_IN these_DT samples_NNS was_VBD a_DT single_JJ nucleotide_NN (_( A/G_NP )_) at_IN position_NN -99_CD of_IN the_DT HCV_NP genome_NN ._SENT Determination_NN of_IN a_DT sample_NN as_IN subtype_NN 1a_NP or_CC 1b_NP by_IN LiPA_NP is_VBZ on_IN the_DT basis_NN of_IN this_DT single_JJ A/G_NP difference_NN at_IN position_NN -99_CD ,_, with_IN LiPA_NP probe_VBP 5_CD corresponding_JJ to_TO an_DT A_DT residue_NN at_IN nucleotide_NN -99_CD and_CC LiPA_NP probe_VBP 6_CD corresponding_JJ to_TO a_DT G_NP residue_NN at_IN this_DT position_NN ._SENT All_DT six_CD samples_NNS with_IN discordant_JJ results_NNS analyzed_VBD had_VBD a_DT G_NP residue_NN at_IN this_DT position_NN ,_, consistent_JJ with_IN identification_NN of_IN these_DT samples_NNS as_IN subtype_NN 1b_NN by_IN LiPA_NP analysis_NN of_IN the_DT 5_CD '_POS UTR_NP ._SENT However_RB ,_, all_DT six_CD samples_NNS were_VBD clearly_RB subtype_NN 1a_NP by_IN NS-5b_NP sequence_NN analysis_NN ._SENT One_CD of_IN the_DT samples_NNS with_IN discrepant_JJ results_NNS listed_VBN in_IN Table_NP was_VBD subtype_NN 1a_NN by_IN NS-5b_NP sequence_NN analysis_NN but_CC genotype_NN type_NN 1_CD by_IN LiPA_NP and_CC could_MD not_RB be_VB subtyped_VBN by_IN LiPA_NP ._SENT Subsequent_JJ analysis_NN of_IN over_RB 1,000_CD samples_NNS by_IN LiPA_NP in_IN our_PP$ laboratory_NN indicated_VBD that_IN a_DT significant_JJ proportion_NN (_( 7.7_CD %_NN )_) of_IN HCV_NP genotype_NN 1_CD samples_NNS cannot_MD be_VB subtyped_VBN by_IN LiPA_NP (_( see_NN Fig._NN )_) ._SENT Many_JJ of_IN these_DT have_VBP LiPA_NP band_NN pattern_NN 1_CD ,_, 2_CD ,_, 3_CD ,_, 4_CD ,_, 5_CD ,_, 6_CD ._SENT In_IN order_NN to_TO investigate_VB these_DT further_RBR ,_, DNA_NP sequencing_NP analysis_NN was_VBD performed_VBN for_IN 10_CD samples_NNS that_WDT were_VBD classified_VBN as_IN type_NN 1_CD by_IN LiPA_NP but_CC that_WDT could_MD not_RB be_VB subtyped_VBN by_IN LiPA_NP ._SENT The_DT genotypes_NNS of_IN all_DT 10_CD of_IN these_DT were_VBD unambiguously_RB subtype_NN 1a_NN by_IN sequencing_VBG of_IN the_DT NS-5b_NP gene_NN (_( data_NNS not_RB shown_VBN )_) ._SENT However_RB ,_, sequence_NN analysis_NN of_IN the_DT 5_CD '_POS UTR_NP of_IN these_DT 10_CD samples_NNS with_IN LiPA_NP band_NN pattern_NN 1_CD ,_, 2_CD ,_, 3_CD ,_, 4_CD ,_, 5_CD ,_, 6_CD demonstrated_VBD a_DT heterogeneous_JJ pattern_NN ,_, with_IN both_DT A_NP and_CC G_NP nucleotides_NNS identified_VBN at_IN position_NN -99_CD (_( Fig._NN and_CC )_) ._SENT In_IN some_DT samples_NNS ,_, almost_RB equal_JJ proportions_NNS of_IN both_DT nucleotides_NNS were_VBD present_JJ (_( a_DT heterozygous_JJ pattern_NN )_) ;_: in_IN other_JJ samples_NNS ,_, the_DT peak_NN for_IN one_CD nucleotide_NN was_VBD higher_JJR than_IN that_DT for_IN the_DT other_JJ ._SENT Digestion_NN of_IN RT-PCR_NP products_NNS of_IN type_NN 1_CD isolates_NNS with_IN Alw26I_NP ._SENT |_SYM The_NP 5_CD '_POS UTR_NP RT-PCR_NP products_NNS of_IN six_CD of_IN the_DT type_NN 1_CD samples_NNS whose_WP$ sequences_NNS are_VBP presented_VBN in_IN Fig._NN as_RB well_RB as_IN those_DT of_IN subtype_NN 1a_NN and_CC subtype_NN 1b_NN controls_NNS were_VBD subjected_VBN to_TO restriction_NN enzyme_NN digestion_NN with_IN Alw26I_NP in_IN order_NN to_TO differentiate_VB between_IN a_DT G_NP residue_NN at_IN position_NN -99_CD (_( subtype_NN 1b_NN pattern_NN )_) and_CC an_DT A_NP residue_NN at_IN this_DT position_NN (_( subtype_NN 1a_NP pattern_NN )_) ._SENT Restriction_NN enzyme_NN digestion_NN of_IN all_DT six_CD type_NN 1_CD samples_NNS with_IN LiPA_NP band_NN pattern_NN 1_CD ,_, 2_CD ,_, 3_CD ,_, 4_CD ,_, 5_CD ,_, 6_CD demonstrated_VBD a_DT heterogeneous_JJ pattern_NN ._SENT These_DT results_NNS confirmed_VBD the_DT results_NNS of_IN sequencing_VBG analysis_NN of_IN the_DT 5_CD '_POS UTR_NN that_IN samples_NNS with_IN LiPA_NP banding_VBG pattern_NN 1_CD ,_, 2_CD ,_, 3_CD ,_, 4_CD ,_, 5_CD ,_, 6_CD carry_NN both_CC an_DT A_NP residue_NN and_CC a_DT G_NP residue_NN at_IN position_NN -99_CD (_( Fig._NN and_CC )_) and_CC demonstrated_VBD that_IN restriction_NN enzyme_NN digestion_NN is_VBZ a_DT rapid_JJ method_NN of_IN analyzing_VBG these_DT samples_NNS ._SENT The_DT patterns_NNS observed_VBN for_IN HCV_NP samples_NNS with_IN both_CC an_DT A_NP residue_NN and_CC a_DT G_NP residue_NN at_IN position_NN -99_CD could_MD potentially_RB be_VB explained_VBN by_IN the_DT presence_NN of_IN a_DT mixed_JJ subtype_NN 1a_NN and_CC 1b_JJ infection_NN ._SENT Mixing_VBG of_IN subtype_NN 1a_NN and_CC subtype_NN 1b_JJ controls_NNS at_IN a_DT 1:1_CD ratio_NN also_RB demonstrated_VBD a_DT heterogeneous_JJ pattern_NN by_IN Alw26_NP I_NP digestion_NN ,_, similar_JJ to_TO the_DT pattern_NN for_IN the_DT samples_NNS that_WDT were_VBD type_NN 1_CD but_CC unsubtypeable_JJ by_IN LiPA_NP ._SENT However_RB ,_, at_IN a_DT subtype_NN 1a_NN to_TO subtype_NN 1b_JJ ratio_NN of_IN 1:4_CD ,_, the_DT uncut_JJ pattern_NN for_IN subtype_NN 1a_NP was_VBD very_RB difficult_JJ to_TO discern_VB ._SENT We_PP also_RB analyzed_VBD artificially_RB mixed_JJ subtypes_NNS by_IN LiPA_NP and_CC demonstrated_VBD a_DT mixed_JJ LiPA_NP 1_CD ,_, 2_CD ,_, 3_CD ,_, 4_CD ,_, 5_CD ,_, 6_CD banding_VBG pattern_NN with_IN a_DT 1:1_CD ratio_NN of_IN subtype_NN 1a_NN to_TO subtype_NN 1b_NN ;_: however_RB ,_, with_IN a_DT 1:4_CD ratio_NN the_DT pattern_NN for_IN subtype_NN 1a_NP was_VBD very_RB difficult_JJ to_TO discern_VB ,_, and_CC with_IN a_DT 1:8_CD ratio_NN only_RB the_DT pattern_NN for_IN subtype_NN 1b_NN could_MD be_VB detected_VBN (_( data_NNS not_RB shown_VBN )_) ._SENT Distribution_NN of_IN HCV_NP genotypes_NNS among_IN samples_NNS analyzed_VBN by_IN LiPA_NP versus_CC NS-5b_NP sequence_NN analysis_NN ._SENT |_SYM A_DT total_NN of_IN 247_CD samples_NNS recovered_VBN from_IN 1996_CD to_TO 1998_CD were_VBD analyzed_VBN by_IN NS-5b_NP sequence_NN analysis_NN by_IN using_VBG the_DT algorithm_NN described_VBD above_IN ._SENT A_DT total_NN of_IN 1,035_CD samples_NNS recovered_VBN from_IN 1998_CD to_TO 2001_CD were_VBD analyzed_VBN by_IN LiPA_NP ._SENT Figure_NN shows_VBZ a_DT comparison_NN of_IN the_DT distribution_NN of_IN genotypes_NNS obtained_VBN in_IN our_PP$ laboratory_NN by_IN the_DT two_CD methods_NNS ._SENT Samples_NNS that_WDT could_MD not_RB be_VB typed_VBN by_IN RT-PCR_NP were_VBD eliminated_VBN from_IN the_DT analysis_NN :_: for_IN samples_NNS that_WDT were_VBD known_VBN to_TO be_VB HCV_NP positive_JJ by_IN either_DT branched_VBN DNA_NN testing_NN or_CC RT-PCR_NP ,_, there_EX was_VBD a_DT 2.9_CD %_NN RT-PCR_NP failure_NN rate_NN for_IN LiPA_NP and_CC a_DT 1.4_CD %_NN failure_NN rate_NN for_IN sequence_NN analysis_NN of_IN the_DT NS-5b_NP region_NN ._SENT The_DT total_JJ distributions_NNS of_IN the_DT genotypes_NNS were_VBD very_RB consistent_JJ between_IN the_DT two_CD methods_NNS ._SENT However_RB ,_, there_EX was_VBD a_DT marked_JJ difference_NN in_IN the_DT distribution_NN of_IN subtype_NN 1a_NN versus_CC subtype_NN 1b_NN ._SENT The_DT distribution_NN by_IN NS-5b_NP sequence_NN analysis_NN was_VBD 64.4_CD %_NN subtype_NN 1a_NP and_CC 16.6_CD %_NN subtype_NN 1b_NN ._SENT In_IN contrast_NN ,_, LiPA_NP analysis_NN resulted_VBD in_IN an_DT almost_RB equal_JJ distribution_NN of_IN subtype_NN 1a_NN versus_CC subtype_NN 1b_NN (_( 35_CD versus_IN 30_CD %_NN )_) ._SENT Thus_RB ,_, LiPA_NP identified_VBD samples_NNS as_IN subtype_NN 1b_NN at_IN a_DT 13_CD %_NN greater_JJR frequency_NN than_IN NS-5b_NP sequence_NN analysis_NN did_VBD ._SENT Of_IN the_DT samples_NNS that_WDT were_VBD HCV_NP genotype_NN 1_CD ,_, LiPA_NP identified_VBD samples_NNS as_IN subtype_NN 1b_NN with_IN a_DT 21_CD %_NN greater_JJR frequency_NN ._SENT In_IN addition_NN ,_, by_IN LiPA_NP analysis_NN 33_CD samples_NNS (_( 3.2_CD %_NN )_) were_VBD untypeable_JJ and_CC 82_CD isolates_NNS (_( 7.9_CD %_NN )_) were_VBD called_VBN type_NN 1_CD but_CC could_MD not_RB be_VB further_RBR subtyped_JJ ._SENT A_DT total_NN of_IN 59_CD samples_NNS (_( 5.7_CD %_NN )_) were_VBD genotype_NN 1_CD ,_, unsubtypeable_JJ with_IN band_NN pattern_NN 1_CD ,_, 2_CD ,_, 3_CD ,_, 4_CD ,_, 5_CD ,_, 6_CD and_CC likely_RB had_VBD both_CC an_DT A_NP residue_NN and_CC a_DT G_NP residue_NN at_IN position_NN -99_CD ._SENT By_IN subsequent_JJ NS-5b_NP sequence_NN analysis_NN ,_, 4_CD of_IN 4_CD of_IN the_DT untypeable_JJ samples_NNS and_CC 15_CD of_IN 15_CD of_IN the_DT type_NN 1_CD ,_, unsubtypeable_JJ samples_NNS were_VBD shown_VBN to_TO be_VB HCV_NP genotype_NN 1a_NP (_( data_NN not_RB shown_VBN )_) ._SENT FIG._NN 1_CD ._SENT |_SYM NS-5b_NP sequence_NN analysis_NN of_IN samples_NNS with_IN discrepant_JJ results_NNS ._SENT NS-5b_NP sequence_NN analysis_NN of_IN samples_NNS with_IN discrepant_JJ results_NNS ._SENT The_DT algorithm_NN used_VBN to_TO define_VB HCV_NP genotype_NN by_IN NS-5b_NP sequence_NN analysis_NN is_VBZ described_VBN in_IN Materials_NPS and_CC Methods_NP ._SENT The_DT key_JJ nucleotides_NNS associated_VBN with_IN subtypes_NNS 1a_NP and_CC 1b_NP are_VBP numbered_VBN and_CC boxed_VBN ._SENT Sequence_NN results_NNS are_VBP shown_VBN only_RB for_IN these_DT key_JJ nucleotides_NNS ._SENT Nucleotide_NN 01_CD in_IN the_DT algorithm_NN corresponds_VBZ to_TO nucleotide_NN 7975_CD in_IN the_DT HCV_NP type_NN 1_CD prototype_NN sequence_NN ._SENT The_DT rightmost_JJ column_NN shows_VBZ the_DT total_JJ number_NN of_IN mismatches_NNS of_IN 222_CD bp_NN analyzed_VBD compared_VBN to_TO consensus_NN subtype_NN 1a_NN or_CC subtype_NN 1b_JJ sequences_NNS ._SENT FIG._NN 2_CD ._SENT |_SYM DNA_NP sequencing_NP analysis_NN of_IN the_DT 5_CD '_POS UTR_NN for_IN control_NN subtype_NN 1a_NN and_CC subtype_NN 1b_JJ samples_NNS (_( cases_NNS A_NP and_CC B_NP )_) ,_, for_IN six_CD of_IN the_DT samples_NNS from_IN Fig._NN DNA_NN sequencing_VBG analysis_NN of_IN the_DT 5_CD '_POS UTR_NN for_IN control_NN subtype_NN 1a_NN and_CC subtype_NN 1b_JJ samples_NNS (_( cases_NNS A_NP and_CC B_NP )_) ,_, for_IN six_CD of_IN the_DT samples_NNS from_IN Fig._NN with_IN discrepant_JJ results_NNS for_IN subtypes_NNS 1a_NP and_CC 1b_JJ (_( cases_NNS 1_CD to_TO 6_CD )_) ,_, and_CC for_IN 10_CD samples_NNS that_WDT LiPA_NP classified_VBD as_IN type_NN 1_CD but_CC that_WDT were_VBD unsubtypeable_JJ by_IN LiPA_NP (_( cases_NNS 9_CD to_TO 18_CD )_) ._SENT All_DT of_IN the_DT samples_NNS had_VBD identical_JJ 5_CD '_POS UTR_NP sequences_NNS with_IN the_DT exception_NN of_IN the_DT nucleotide_NN regions_NNS at_IN positions_NNS -99_CD and_CC -138_CD ._SENT The_DT banding_VBG pattern_NN obtained_VBN by_IN LiPA_NP is_VBZ shown_VBN in_IN parentheses_NNS at_IN the_DT right_NN ._SENT C_SYM region_NN ,_, core_JJ region_NN ;_: F_NP ,_, forward_RB sequencing_VBG primer_NN ;_: R_NP ,_, reverse_JJ sequencing_VBG primer_NN ;_: A/G_NP ,_, both_CC an_DT A-residue_NP peak_NN and_CC a_DT G-residue_NP peak_NN were_VBD observed_VBN at_IN an_DT approximately_RB equal_JJ peak_NN ratio_NN by_IN sequence_NN analysis_NN ;_: A/g_NP ,_, a_DT higher_JJR peak_NN was_VBD observed_VBN for_IN the_DT A_NP residue_NN than_IN for_IN the_DT G_NP residue_NN by_IN sequence_NN analysis_NN ._SENT FIG._NN 5_CD ._SENT |_SYM Comparison_NN of_IN the_DT distributions_NNS of_IN HCV_NP genotypes_NNS obtained_VBN by_IN LiPA_NP versus_CC those_DT obtained_VBN by_IN NS-5b_NP sequence_NN analysis_NN ._SENT Comparison_NN of_IN the_DT distributions_NNS of_IN HCV_NP genotypes_NNS obtained_VBN by_IN LiPA_NP versus_CC those_DT obtained_VBN by_IN NS-5b_NP sequence_NN analysis_NN ._SENT FIG._NN 3_CD ._SENT |_SYM Representative_NP sequence_NN analysis_NN for_IN HCV_NP subtype_NN 1a_NP and_CC 1b_JJ controls_NNS and_CC for_IN a_DT type_NN 1_CD ,_, unsubtypeable_JJ isolate_NN with_IN LiPA_NP banding_VBG pattern_NN 1_CD ,_, 2_CD ,_, 3_CD ,_, 4_CD ,_, 5_CD ,_, 6_CD ._SENT Representative_JJ sequence_NN analysis_NN for_IN HCV_NP subtype_NN 1a_NP and_CC 1b_JJ controls_NNS and_CC for_IN a_DT type_NN 1_CD ,_, unsubtypeable_JJ isolate_NN with_IN LiPA_NP banding_VBG pattern_NN 1_CD ,_, 2_CD ,_, 3_CD ,_, 4_CD ,_, 5_CD ,_, 6_CD ._SENT Position_NN -99_CD is_VBZ indicated_VBN by_IN the_DT arrows_NNS ._SENT Samples_NNS found_VBD to_TO be_VB subtype_NN 1a_NP by_IN LiPA_NP have_VBP an_DT A_DT residue_NN at_IN this_DT position_NN ;_: samples_NNS found_VBD to_TO be_VB subtype_NN 1b_NN have_VBP a_DT G_NP residue_NN ._SENT The_DT heterogeneous_JJ pattern_NN observed_VBN at_IN this_DT nucleotide_NN position_NN for_IN cases_NNS 9_CD to_TO 18_CD from_IN Fig._NN is_VBZ demonstrated_VBN ._SENT Forward_RB (_( plus-strand_NN )_) or_CC reverse_VB (_( minus-strand_NN )_) sequences_NNS are_VBP indicated_VBN ._SENT FIG._NN 4_CD ._SENT |_SYM Digestion_NN of_IN genotype_NN 1_CD RT-PCR_NP products_NNS with_IN Alw26I_NP ._SENT Digestion_NN of_IN genotype_NN 1_CD RT-PCR_NP products_NNS with_IN Alw26I_NP ._SENT Restriction_NN enzyme_NN analysis_NN of_IN the_DT 5_CD '_POS UTR_NN was_VBD performed_VBN for_IN a_DT subset_NN of_IN samples_NNS that_WDT were_VBD genotype_NN 1_CD by_IN LiPA_NP but_CC that_WDT could_MD not_RB be_VB subtyped_VBN by_IN LiPA_NP ._SENT 5_LS '_POS UTR_NP RT-PCR_NP products_NNS were_VBD subjected_VBN to_TO restriction_NN enzyme_NN digestion_NN with_IN Alw26I_NP in_IN order_NN to_TO differentiate_VB between_IN a_DT G_NP residue_NN at_IN position_NN -99_CD (_( subtype_NN 1b_NN pattern_NN )_) and_CC an_DT A_NP residue_NN at_IN this_DT position_NN (_( subtype_NN 1a_NP pattern_NN )_) ._SENT Upper_JJ panel_NN ,_, diagram_NN showing_VBG the_DT position_NN of_IN Alw26I_NP restriction_NN sites_NNS within_IN the_DT 340-bp_JJ 5_CD '_POS UTR_NP RT-PCR_NP product_NN ;_: bottom_JJ panel_NN ,_, 2_CD %_NN ethidium_NN bromide-stained_VBD agarose_JJ gel_NN of_IN restriction_NN enzyme_NN products_NNS ._SENT The_DT contents_NNS of_IN the_DT lanes_NNS are_VBP as_RB follows_VBZ (_( the_DT lane_JJ numbers_NNS represent_VBP the_DT unnumbered_JJ lanes_NNS from_IN left_VBN to_TO right_NN ,_, respectively_RB )_) :_: lanes_NNS 1_CD and_CC 12_CD ,_, molecular_JJ weight_NN markers_NNS ;_: lane_NN 2_CD ,_, subtype_NN 1b_JJ control_NN demonstrating_VBG 209-_CD and_CC 91-bp_NN bands_NNS ;_: lane_NN 3_CD ,_, subtype_NN 1a_NP control_NN demonstrating_VBG a_DT 300-bp_JJ band_NN ;_: lanes_NNS 4_CD and_CC 8_CD ,_, mixtures_NNS of_IN subtype_NN 1a_NN and_CC subtype_NN 1b_JJ control_NN RT-PCR_NP products_NNS at_IN 1:1_CD and_CC 1:4_CD ratios_NNS ,_, respectively_RB ;_: lanes_NNS 5_CD to_TO 7_CD and_CC 9_CD to_TO 11_CD ,_, genotype_NN 1_CD samples_NNS that_WDT were_VBD unsubtypeable_JJ by_IN LiPA_NP and_CC that_WDT were_VBD shown_VBN to_TO have_VB both_PDT an_DT A_NP residue_NN and_CC a_DT G_NP residue_NN at_IN position_NN -99_CD ._SENT Sample_NN numbers_NNS at_IN the_DT bottom_NN correspond_VB to_TO those_DT in_IN Fig._NN ._SENT TABLE_NN 1_CD |_SYM Comparison_NN of_IN HCV_NP genotype_NN by_IN NS-5b_NP sequence_NN analysis_NN versus_IN LiPA_NP It_PP has_VBZ been_VBN suggested_VBN that_DT interrogation_NN of_IN the_DT HCV_NP 5_CD '_POS UTR_NP ,_, although_IN less_RBR heterogeneous_JJ than_IN other_JJ regions_NNS of_IN the_DT viral_JJ genome_NN ,_, correlates_VBZ well_RB with_IN and_CC is_VBZ more_RBR sensitive_JJ than_IN interrogation_NN of_IN other_JJ genomic_JJ regions_NNS of_IN HCV_NP and_CC is_VBZ sufficient_JJ for_IN determining_VBG the_DT HCV_NP genotype_NN ._SENT Although_IN direct_JJ sequencing_NP is_VBZ more_RBR time-consuming_JJ and_CC labor-intensive_JJ than_IN LiPA_NP ,_, we_PP have_VBP not_RB experienced_VBN the_DT failure_NN rates_NNS that_WDT have_VBP been_VBN reported_VBN by_IN other_JJ investigators_NNS for_IN sequencing_VBG of_IN the_DT NS-5b_NP region_NN ._SENT Analysis_NN of_IN the_DT 5_CD '_POS UTR_NP by_IN LiPA_NP with_IN the_DT INNO-LiPA_NP HCV_NP II_NP kit_NN provides_VBZ a_DT fast_JJ and_CC easy_JJ method_NN for_IN determination_NN of_IN the_DT HCV_NP genotype_NN ._SENT Although_IN the_DT 5_CD '_POS UTR_NN is_VBZ less_RBR polymorphic_JJ ,_, the_DT results_NNS obtained_VBN by_IN LiPA_NP correlate_VBP well_RB with_IN those_DT obtained_VBN by_IN sequence_NN analysis_NN of_IN the_DT NS-5b_NP region_NN for_IN determination_NN of_IN the_DT genotype_NN ,_, with_IN 100_CD %_NN concordance_NN in_IN this_DT study_NN ._SENT However_RB ,_, several_JJ reports_NNS have_VBP indicated_VBN that_DT analysis_NN of_IN the_DT 5_CD '_POS UTR_NP cannot_MD accurately_RB differentiate_VB HCV_NP subtypes_NNS ._SENT This_DT is_VBZ likely_RB because_IN of_IN the_DT relative_JJ lack_NN of_IN heterogeneity_NN of_IN the_DT 5_CD '_POS UTR_NP ._SENT Consistent_JJ with_IN the_DT previous_JJ reports_NNS ,_, in_IN a_DT direct_JJ comparison_NN of_IN 63_CD samples_NNS in_IN this_DT study_NN ,_, LiPA_NP misclassified_VBN similar20_JJ %_NN of_IN HCV_NP subtype_NN 1a_NP isolates_VBZ as_IN subtype_NN 1b_NN ._SENT Thus_RB ,_, LiPA_NP tends_VBZ to_TO overcall_VB genotype_NN 1_CD samples_NNS as_IN subtype_NN 1b_NN ._SENT Sequencing_VBG of_IN both_CC the_DT 5_CD '_POS UTR_NP and_CC the_DT NS-5b_NP gene_NN for_IN the_DT isolates_NNS in_IN six_CD of_IN these_DT samples_NNS with_IN discrepant_JJ results_NNS indicated_VBD that_IN the_DT isolates_NNS were_VBD clearly_RB genotype_NN 1a_NN by_IN analysis_NN of_IN 222_CD bp_NN of_IN NS-5b_NP gene_NN ,_, but_CC because_IN they_PP had_VBD a_DT G_NP nucleotide_NN at_IN position_NN -99_CD they_PP were_VBD genotyped_VBN as_IN subtype_NN 1b_NN by_IN LiPA_NP ._SENT Consistent_JJ with_IN other_JJ reports_NNS ,_, we_PP have_VBP also_RB identified_VBN by_IN NS-5b_NP gene_NN sequencing_VBG a_DT genotype_NN 1b_JJ isolate_NN that_WDT had_VBD an_DT A_DT residue_NN at_IN position_NN -99_CD but_CC that_WDT was_VBD misclassified_VBN as_IN type_NN 1a_NP by_IN LiPA_NP analysis_NN (_( data_NNS not_RB shown_VBN )_) ._SENT These_DT results_NNS could_MD be_VB explained_VBN by_IN (_( i_NP )_) a_DT mixed_JJ infection_NN of_IN subtype_NN 1a_NP and_CC 1b_NP isolates_VBZ ;_: (_( ii_NP )_) infidelity_NN of_IN the_DT PCR_NP introduced_VBD by_IN Taq_NP polymerase_NN ,_, although_IN this_DT is_VBZ unlikely_JJ to_TO occur_VB consistently_RB at_IN a_DT single_JJ nucleotide_NN ;_: (_( iii_NP )_) recombination_NN between_IN different_JJ HCV_NP subtypes_NNS ;_: or_CC (_( iv_NN )_) an_DT A/G_NP polymorphism_NN that_WDT may_MD exist_VB at_IN nucleotide_NN -99_CD in_IN HCV_NP isolates_VBZ ._SENT In_IN the_DT last_JJ scenario_NN ,_, either_CC an_DT A_NP residue_NN or_CC a_DT G_NP residue_NN ,_, or_CC both_DT nucleotides_NNS ,_, could_MD be_VB present_JJ in_IN subtype_NN 1a_NN or_CC subtype_NN 1b_JJ isolates_NNS ._SENT This_DT would_MD invalidate_VB the_DT use_NN of_IN this_DT single_JJ nucleotide_NN to_TO differentiate_VB subtype_NN 1a_NN and_CC subtype_NN 1b_JJ isolates_NNS ._SENT In_IN addition_NN ,_, 10_CD genotype_NN 1_CD isolates_NNS that_WDT could_MD not_RB be_VB subtyped_VBN by_IN LiPA_NP and_CC that_WDT had_VBD the_DT band_NN pattern_NN 1_CD ,_, 2_CD ,_, 3_CD ,_, 4_CD ,_, 5_CD ,_, 6_CD had_VBD both_DT an_DT A_NP residue_NN and_CC a_DT G_NP residue_NN in_IN the_DT nucleotide_NN at_IN position_NN -99_CD (_( Fig._NN to_TO )_) but_CC were_VBD clearly_RB genotype_NN 1a_NP by_IN NS-5b_NP sequence_NN analysis_NN ._SENT These_DT results_NNS could_MD be_VB explained_VBN by_IN a_DT mixed_JJ infection_NN with_IN subtypes_NNS 1a_NP and_CC 1b_NP or_CC by_IN an_DT A/G_NP sequence_NN polymorphism_NN at_IN position_NN -99_CD ._SENT Although_IN we_PP cannot_MD rule_VB out_RP the_DT possibility_NN that_IN these_DT samples_NNS represent_VBP mixed_JJ infections_NNS with_IN genotypes_NNS 1a_NP and_CC 1b_NP ,_, 5_CD '_POS UTR_NP restriction_NN fragment_NN length_NN polymorphism_NN analysis_NN and_CC LiPA_NP evaluation_NN of_IN artificial_JJ mixtures_NNS of_IN isolates_NNS indicate_VBP that_IN there_EX would_MD have_VB to_TO be_VB an_DT approximately_RB equal_JJ mix_NN of_IN types_NNS 1a_NP and_CC 1b_NP to_TO obtain_VB the_DT patterns_NNS observed_VBD (_( Fig._NN ;_: see_VB also_RB Results_NNS )_) ._SENT A_DT sequence_NN polymorphism_NN is_VBZ a_DT more_RBR likely_JJ explanation_NN ,_, as_IN we_PP would_MD have_VB expected_VBN to_TO identify_VB the_DT isolates_NNS in_IN at_IN least_JJS some_DT of_IN these_DT samples_NNS as_IN genotype_NN 1b_JJ by_IN sequencing_VBG of_IN the_DT NS-5b_NP region_NN if_IN they_PP were_VBD truly_RB mixed_VBN infections_NNS with_IN types_NNS 1a_NP and_CC 1b_NP in_IN approximately_RB equal_JJ proportions_NNS ._SENT To_TO our_PP$ knowledge_NN ,_, this_DT is_VBZ the_DT first_JJ report_NN that_IN HCV_NP genotype_NN 1a_NP isolates_VBZ from_IN a_DT single_JJ patient_NN sample_NN can_MD have_VB both_CC an_DT A_NP residue_NN and_CC a_DT G_NP residue_NN at_IN position_NN -99_CD ._SENT The_DT isolates_NNS in_IN a_DT total_NN of_IN 59_CD of_IN 1,035_CD samples_NNS tested_VBN by_IN LiPA_NP (_( 5.7_CD %_NN )_) gave_VBD the_DT band_NN pattern_NN 1_CD ,_, 2_CD ,_, 3_CD ,_, 4_CD ,_, 5_CD ,_, 6_CD and_CC likely_RB have_VB both_PDT an_DT A_NP residue_NN and_CC a_DT G_NP residue_NN at_IN this_DT position_NN ._SENT The_DT data_NNS presented_VBD here_RB are_VBP consistent_JJ with_IN what_WP would_MD be_VB expected_VBN if_IN the_DT A/G_NN at_IN nucleotide_NN at_IN position_NN -99_CD was_VBD a_DT sequence_NN polymorphism_NN rather_RB than_IN segregating_VBG with_IN a_DT particular_JJ subtype_NN :_: either_CC an_DT A_NP residue_NN or_CC a_DT G_NP residue_NN can_MD be_VB present_JJ at_IN nucleotide_NN -99_CD in_IN both_DT genotype_NN 1a_NN and_CC genotype_NN 1b_JJ isolates_NNS ,_, and_CC in_IN some_DT cases_NNS ,_, both_CC nucleotides_NNS can_MD be_VB present_JJ in_IN a_DT single_JJ genotype_NN as_IN part_NN of_IN the_DT group_NN of_IN quasispecies_NNS present_JJ in_IN an_DT infected_JJ patient_NN ._SENT The_DT hypothesis_NN that_IN the_DT A/G_NN at_IN position_NN -99_CD is_VBZ a_DT sequence_NN polymorphism_NN in_IN the_DT HCV_NP genome_NN that_WDT cannot_MD differentiate_VB between_IN subtypes_NNS 1a_NP and_CC 1b_NP is_VBZ further_RBR supported_VBN by_IN the_DT genotype_NN distribution_NN in_IN our_PP$ laboratory_NN of_IN the_DT isolates_NNS in_IN over_IN 200_CD samples_NNS analyzed_VBN by_IN NS-5b_NP sequencing_NP from_IN 1996_CD to_TO 1998_CD and_CC over_IN 1,000_CD samples_NNS analyzed_VBN by_IN LiPA_NP from_IN 1998_CD to_TO 2001_CD ._SENT The_DT distribution_NN in_IN our_PP$ laboratory_NN of_IN subtype_NN 1a_NN versus_CC subtype_NN 1b_NN isolates_NNS was_VBD 64_CD and_CC 17_CD %_NN ,_, respectively_RB ,_, by_IN NS-5b_NP sequence_NN analysis_NN ._SENT This_DT distribution_NN is_VBZ consistent_JJ with_IN those_DT in_IN reports_NNS of_IN studies_NNS from_IN various_JJ regions_NNS throughout_IN the_DT United_NP States_NPS ,_, which_WDT have_VBP indicated_VBN that_IN similar60_JJ and_CC similar20_JJ %_NN of_IN U.S._NP isolates_NNS are_VBP genotypes_NNS 1a_NP and_CC 1b_NP ,_, respectively_RB ._SENT In_IN contrast_NN ,_, the_DT distributions_NNS of_IN subtype_NN 1a_NN versus_CC subtype_NN 1b_NN isolates_VBZ by_IN LiPA_NP analysis_NN were_VBD 35_CD and_CC 30_CD %_NN ,_, respectively_RB ._SENT Thus_RB ,_, there_EX was_VBD almost_RB an_DT equal_JJ distribution_NN of_IN subtype_NN 1a_NN versus_CC subtype_NN 1b_NN isolates_VBZ by_IN LiPA_NP ,_, consistent_JJ with_IN an_DT inability_NN of_IN the_DT A/G_NN at_IN position_NN -99_CD to_TO distinguish_VB genotype_NN 1a_NN from_IN genotype_NN 1b_NN ._SENT Interestingly_RB ,_, these_DT distribution_NN data_NNS are_VBP consistent_JJ with_IN those_DT in_IN reports_NNS of_IN other_JJ studies_NNS conducted_VBN in_IN the_DT United_NP States_NP that_WDT have_VBP used_VBN the_DT 5_CD '_POS UTR_NN for_IN genotyping_NN ._SENT Although_IN we_PP cannot_MD rule_VB out_RP the_DT possibility_NN that_IN the_DT relative_JJ incidence_NN of_IN type_NN 1b_NN has_VBZ increased_VBN dramatically_RB at_IN our_PP$ institution_NN in_IN the_DT past_JJ 3_CD years_NNS ,_, this_DT is_VBZ unlikely_JJ ,_, as_IN the_DT population_NN seen_VBN over_IN that_DT period_NN was_VBD very_RB consistent_JJ ._SENT In_IN addition_NN ,_, distribution_NN data_NNS for_IN over_IN 1,000_CD samples_NNS analyzed_VBN by_IN LiPA_NP in_IN our_PP$ laboratory_NN over_IN the_DT past_JJ 3_CD years_NNS indicate_VBP that_IN similar30_JJ %_NN of_IN genotype_NN 1a_NN isolates_NNS were_VBD likely_RB misclassified_VBN by_IN LiPA_NP as_IN either_DT genotype_NN 1b_NN or_CC type_NN 1_CD ,_, unsubtypeable_JJ ._SENT These_DT data_NNS correlate_VBP well_RB with_IN those_DT obtained_VBN when_WRB the_DT results_NNS of_IN LiPA_NP and_CC NS-5b_NP sequencing_NP were_VBD compared_VBN in_IN parallel_NN ._SENT Interestingly_RB ,_, these_DT data_NNS are_VBP consistent_JJ with_IN those_DT in_IN the_DT original_JJ paper_NN by_IN Stuyver_NP et_FW al._FW describing_VBG the_DT use_NN of_IN reverse_JJ hybridization_NN in_IN the_DT 5_CD '_POS UTR_NP for_IN HCV_NP genotyping_NN ._SENT Of_IN 10_CD prototype_NN 1a_NN and_CC 1b_JJ sequences_NNS used_VBN to_TO define_VB reverse_JJ hybridization_NN probes_NNS for_IN this_DT assay_NN ,_, only_RB 70_CD %_NN had_VBD the_DT pattern_NN of_IN an_DT A_NP residue_NN for_IN type_NN 1a_NP and_CC a_DT G_NP residue_NN for_IN type_NN 1b_NN at_IN position_NN -99_CD ._SENT Of_IN the_DT type_NN 1a_NN isolates_NNS ,_, 30_CD %_NN (_( one_CD of_IN three_CD )_) had_VBD a_DT G_NP residue_NN at_IN this_DT position_NN and_CC would_MD have_VB been_VBN misclassified_VBN as_IN type_NN 1b_NN ;_: similarly_RB ,_, of_IN the_DT type_NN 1b_JJ isolates_NNS ,_, 30_CD %_NN (_( two_CD of_IN seven_CD )_) had_VBD an_DT A_DT residue_NN at_IN this_DT position_NN and_CC would_MD have_VB been_VBN misclassified_VBN as_IN type_NN 1a_NP ._SENT Despite_IN mounting_VBG evidence_NN that_IN analysis_NN of_IN the_DT 5_CD '_POS UTR_NP does_VBZ not_RB accurately_RB differentiate_VB HCV_NP subtypes_NNS ,_, the_DT INNO-LiPA_NP HCV_NP kit_NN II_NP provides_VBZ interpretation_NN criteria_NNS for_IN multiple_JJ subtypes_NNS of_IN HCV_NP ,_, and_CC many_JJ laboratories_NNS use_VBP 5_CD '_POS UTR_NP analysis_NN for_IN determination_NN of_IN HCV_NP subtypes_NNS ._SENT In_IN conclusion_NN ,_, LiPA_NP allows_VBZ the_DT easy_JJ and_CC rapid_JJ determination_NN of_IN HCV_NP genotypes_NNS but_CC fails_VBZ to_TO determine_VB the_DT subtypes_NNS of_IN isolates_NNS in_IN many_JJ samples_NNS and_CC misclassifies_VBZ a_DT significant_JJ percentage_NN of_IN type_NN 1a_NP isolates_VBZ as_IN type_NN 1b_NN ._SENT These_DT isolates_NNS are_VBP unlikely_JJ to_TO be_VB clinically_RB significant_JJ ,_, as_IN most_JJS studies_NNS have_VBP identified_VBN clinical_JJ differences_NNS only_RB between_IN those_DT infected_JJ with_IN type_NN 1_CD isolates_NNS and_CC those_DT infected_JJ with_IN non-type_NN 1_CD isolates_NNS ._SENT However_RB ,_, these_DT findings_NNS have_VBP implications_NNS for_IN epidemiologic_JJ studies_NNS ,_, as_RB well_RB as_IN for_IN studies_NNS investigating_VBG clinical_JJ differences_NNS between_IN patients_NNS infected_VBN with_IN HCV_NP genotypes_NNS 1a_NP and_CC 1b_NP ._SENT If_IN 5_CD '_POS UTR_NP analysis_NN overrepresents_NNS genotype_NN 1b_NN or_CC cannot_MD differentiate_VB between_IN genotypes_NNS 1a_NP and_CC 1b_NP ,_, any_DT clinical_JJ difference_NN between_IN patients_NNS infected_VBN with_IN genotypes_NNS 1a_NP and_CC 1b_NP will_MD be_VB diluted_VBN in_IN outcome_NN studies_NNS that_WDT interrogate_VBP the_DT 5_CD '_POS UTR_NN for_IN genotyping_NN ._SENT Indeed_RB ,_, many_JJ studies_NNS in_IN both_CC the_DT United_NP States_NPS and_CC Europe_NP that_WDT have_VBP reported_VBN differences_NNS in_IN outcomes_NNS between_IN patients_NNS infected_VBN with_IN genotypes_NNS 1a_NP and_CC 1b_NP have_VBP used_VBN the_DT NS-5_NP or_CC core_JJ regions_NNS to_TO define_VB the_DT genotype_NN ._SENT On_IN the_DT other_JJ hand_NN ,_, several_JJ studies_NNS that_WDT have_VBP used_VBN the_DT 5_CD '_POS UTR_NN for_IN genotyping_NN have_VBP failed_VBN to_TO find_VB a_DT difference_NN in_IN clinical_JJ outcomes_NNS between_IN type_NN 1a-_NN and_CC type_NN 1b-infected_JJ patients_NNS ._SENT Thus_RB ,_, it_PP is_VBZ possible_JJ that_IN some_DT of_IN the_DT differences_NNS in_IN studies_NNS of_IN the_DT outcomes_NNS of_IN genotype_NN 1b_JJ infections_NNS are_VBP due_JJ to_TO the_DT method_NN of_IN genotyping_VBG used_VBN ._SENT We_PP conclude_VBP that_IN 5_CD '_POS UTR_NP analysis_NN (_( by_IN LiPA_NP analysis_NN or_CC other_JJ methods_NNS )_) is_VBZ sufficient_JJ for_IN determination_NN of_IN the_DT HCV_NP type_NN and_CC can_MD be_VB used_VBN for_IN clinical_JJ purposes_NNS to_TO differentiate_VB type_NN 1_CD from_IN non-type_NN 1_CD isolates_NNS ,_, but_CC determination_NN of_IN subtype_NN should_MD rely_VB on_IN analysis_NN of_IN more_JJR heterogeneous_JJ regions_NNS of_IN the_DT HCV_NP genome_NN ._SENT 